Michael Graeber is a Neurology physician affiliated with Galderma. OpenAlex indexes 40 publications with 3,679 citations (h-index 23); ClinicalTrials.gov lists 21 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Plaque Psoriasis Study in Pediatric Subjects
Sponsor: Galderma R&D
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Model‐informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis
British Journal of Clinical Pharmacology
2026 - Clinical Pharmacology and Safety of Trifarotene, a First‐in‐Class RARγ‐Selective Topical Retinoid
The Journal of Clinical Pharmacology
2020 - 13882 Trifarotene 50 μg/g cream: An effective and safe treatment for moderate facial and truncal acne
Journal of the American Academy of Dermatology
2020 - Randomized phase 3 evaluation of trifarotene 50 μg/g cream treatment of moderate facial and truncal acne
Journal of the American Academy of Dermatology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Miller, MD
University of California, San Francisco (UCSF)
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine
Steven Dekosky, MD
University of Florida
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”